Crossmark Global Holdings’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.81M Sell
134,724
-3,705
-3% -$227K 0.09% 218
2026
Q1
$9.03M Sell
138,429
-3,061
-2% -$224K 0.13% 172
2025
Q4
$11.4M Sell
141,490
-2,914
-2% -$234K 0.16% 146
2025
Q3
$11.8M Sell
144,404
-2,296
-2% -$199K 0.18% 139
2025
Q2
$13.4M Buy
146,700
+1,695
+1% +$152K 0.22% 111
2025
Q1
$13.3M Buy
145,005
+2,789
+2% +$243K 0.23% 104
2024
Q4
$12.1M Sell
142,216
-3,340
-2% -$293K 0.22% 105
2024
Q3
$12.7M Buy
145,556
+37,516
+35% +$3.16M 0.23% 107
2024
Q2
$8.53M Sell
108,040
-2,543
-2% -$209K 0.16% 143
2024
Q1
$9.99M Sell
110,583
-4,176
-4% -$381K 0.19% 138
2023
Q4
$10.1M Sell
114,759
-5,507
-5% -$459K 0.21% 132
2023
Q3
$10.1M Buy
120,266
+455
+0.4% +$41.1K 0.23% 115
2023
Q2
$11.2M Buy
119,811
+1,180
+1% +$111K 0.24% 111
2023
Q1
$11.4M Buy
118,631
+1,403
+1% +$130K 0.27% 99
2022
Q4
$10.7M Buy
117,228
+6,633
+6% +$564K 0.27% 103
2022
Q3
$8.79M Buy
110,595
+432
+0.4% +$36.6K 0.24% 105
2022
Q2
$9.18M Buy
110,163
+674
+0.6% +$55.6K 0.24% 103
2022
Q1
$9M Sell
109,489
-1,269
-1% -$99.4K 0.2% 128
2021
Q4
$8.29M Sell
110,758
-5,861
-5% -$440K 0.18% 140
2021
Q3
$8.83M Buy
116,619
+1,930
+2% +$149K 0.21% 126
2021
Q2
$8.87M Buy
114,689
+5,577
+5% +$431K 0.21% 123
2021
Q1
$7.65M Sell
109,112
-1,043
-0.9% -$78.8K 0.19% 133
2020
Q4
$7.81M Sell
110,155
-2,096
-2% -$132K 0.2% 127
2020
Q3
$6.44M Buy
+112,251
New +$6.71M 0.18% 140
2019
Q1
Sell
-38,264
Closed -$2.24M 1387
2018
Q4
$2.24M Sell
38,264
-2,580
-6% -$162K 0.07% 321
2018
Q3
$2.69M Buy
40,844
+7
+0% +$463 0.07% 322
2018
Q2
$2.7M Sell
40,837
-872
-2% -$58.7K 0.07% 301
2018
Q1
$2.78M Sell
41,709
-2,310
-5% -$155K 0.07% 329
2017
Q4
$2.88M Sell
44,019
-238
-0.5% -$15.4K 0.07% 332
2017
Q3
$2.85M Buy
+44,257
New +$2.86M 0.07% 324
2016
Q3
$2.85M Buy
+44,257
New +$2.61M 0.07% 324

Other funds holding DOX

Crossmark Global Holdings's DOX Position: Q2 2026 in Review

Crossmark Global Holdings reduced its Amdocs (DOX) stake by 2.7% in Q2 2026, selling an estimated $227K and leaving 134,724 shares worth $6.81M. The position accounts for 0.09% of the portfolio, ranked #218.

Crossmark Global Holdings first reported a position in DOX in Q3 2016 and has held it in 31 quarters since. The position peaked at $13.4M in Q2 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Crossmark Global Holdings held 134,724 shares of Amdocs worth $6.81M as of Q2 2026.
  • Crossmark Global Holdings sold 3,705 Amdocs shares in Q2 2026, an estimated $227K.
  • Amdocs made up 0.09% of Crossmark Global Holdings's portfolio in Q2 2026, its #218 holding.
  • Crossmark Global Holdings first reported a position in Amdocs in Q3 2016 and has held it in 31 quarters since.
  • Crossmark Global Holdings's Amdocs position peaked at $13.4M in Q2 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.